JP2010531846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010531846A5 JP2010531846A5 JP2010513952A JP2010513952A JP2010531846A5 JP 2010531846 A5 JP2010531846 A5 JP 2010531846A5 JP 2010513952 A JP2010513952 A JP 2010513952A JP 2010513952 A JP2010513952 A JP 2010513952A JP 2010531846 A5 JP2010531846 A5 JP 2010531846A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- binding fragment
- fragment
- antagonist
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20070468 | 2007-06-28 | ||
| IE2007/0468 | 2007-06-28 | ||
| US3837208P | 2008-03-20 | 2008-03-20 | |
| US61/038,372 | 2008-03-20 | ||
| IE20080209 | 2008-03-20 | ||
| IE2008/0209 | 2008-03-20 | ||
| PCT/EP2008/058339 WO2009000929A2 (en) | 2007-06-28 | 2008-06-27 | Composition and method for treatment of autoimmune disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010531846A JP2010531846A (ja) | 2010-09-30 |
| JP2010531846A5 true JP2010531846A5 (https=) | 2011-08-04 |
| JP5554703B2 JP5554703B2 (ja) | 2014-07-23 |
Family
ID=39758798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010513952A Active JP5554703B2 (ja) | 2007-06-28 | 2008-06-27 | 自己免疫疾患の治療のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8580255B2 (https=) |
| EP (1) | EP2170392A2 (https=) |
| JP (1) | JP5554703B2 (https=) |
| CN (1) | CN101808662A (https=) |
| AU (1) | AU2008267151B2 (https=) |
| CA (1) | CA2691784C (https=) |
| WO (1) | WO2009000929A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100278817A1 (en) * | 2007-07-05 | 2010-11-04 | Opsona Therapeutics Ltd. | Compounds and methods for the treatment of renal disease |
| US9981018B2 (en) | 2010-06-08 | 2018-05-29 | The Cleveland Clinic Foundation | Compositions and methods for modulating toll-like receptor 2 activation |
| WO2011156451A2 (en) * | 2010-06-08 | 2011-12-15 | The Cleveland Clinic Foundation | Compositions and methods for modulating toll-like receptor 2 activation |
| WO2012011100A1 (en) * | 2010-07-19 | 2012-01-26 | Yeda Research And Development Co. Ltd. | Peptides based on the transmembrane domain of a toll-like receptor (tlr) for treatment of tlr-mediated diseases |
| CN103562387A (zh) | 2011-03-03 | 2014-02-05 | 夸克医药公司 | Toll样受体途径的寡核苷酸调剂 |
| US9796979B2 (en) | 2011-03-03 | 2017-10-24 | Quark Pharmaceuticals Inc. | Oligonucleotide modulators of the toll-like receptor pathway |
| EP2970428A4 (en) * | 2013-03-15 | 2016-08-31 | Univ Florida | COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE PROTEINOPATHIES |
| WO2016154586A1 (en) * | 2015-03-26 | 2016-09-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Toll-like receptor 2 ligands and methods of making and using thereof |
| CN107847657A (zh) * | 2015-06-15 | 2018-03-27 | 生命治疗有限公司 | 用于诱导抗炎反应的组合物和方法 |
| EP3735129B1 (en) | 2018-01-02 | 2025-02-05 | Rush University Medical Center | Compositions and methods for treating neurological and other disorders |
| WO2020011869A2 (en) | 2018-07-11 | 2020-01-16 | Roche Innovation Center Copenhagen A/S | Antisense oligonucleotides targeting tlr2 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9927332D0 (en) | 1999-11-18 | 2000-01-12 | Leiv Eiriksson Nyfotek As | Novel antibody and uses thereof |
| US7388080B2 (en) * | 2003-08-20 | 2008-06-17 | University Of Massachusetts | Selective inhibition of toll-like receptor-2 |
| ATE510853T1 (de) * | 2003-09-23 | 2011-06-15 | Univ Muenchen Tech | Tlr2-antagonistischer antikörper und dessen verwendung |
| WO2005039504A2 (en) * | 2003-10-24 | 2005-05-06 | Eisai Co., Ltd. | Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| WO2005079419A2 (en) * | 2004-02-17 | 2005-09-01 | The Regents Of The University Of California | Methods of treating immunopathological disorders |
| AU2005325482B2 (en) * | 2004-12-10 | 2011-06-16 | Novimmune S.A. | Combining therapies targeting multiple toll-like receptors and use thereof |
| CA2596509A1 (en) | 2005-02-14 | 2006-08-24 | Wyeth | Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| EP2139916A1 (en) | 2007-04-26 | 2010-01-06 | Opsona Therapeutics Limited | Toll-like receptor binding epitope and compositions for binding thereto |
-
2008
- 2008-06-27 WO PCT/EP2008/058339 patent/WO2009000929A2/en not_active Ceased
- 2008-06-27 US US12/666,442 patent/US8580255B2/en active Active
- 2008-06-27 AU AU2008267151A patent/AU2008267151B2/en active Active
- 2008-06-27 CA CA2691784A patent/CA2691784C/en active Active
- 2008-06-27 EP EP08774497A patent/EP2170392A2/en not_active Withdrawn
- 2008-06-27 JP JP2010513952A patent/JP5554703B2/ja active Active
- 2008-06-27 CN CN200880104716A patent/CN101808662A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010531846A5 (https=) | ||
| Chu et al. | Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody | |
| ES2514495T3 (es) | Anticuerpos humanizados modificados anti-interleucina-18 | |
| HRP20191341T1 (hr) | Protutijela koja vežu ljudski cgrp receptor | |
| Shaw et al. | Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling | |
| TWI687440B (zh) | Ｓｔ２ｌ拮抗劑及使用方法 | |
| HRP20231031T1 (hr) | Protutijela protiv sars-cov-2 | |
| FI3592384T3 (fi) | Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään | |
| JP2015535820A5 (https=) | ||
| US10618957B2 (en) | Antibody molecules which bind CD79 | |
| JP2022031635A5 (https=) | ||
| HRP20191342T1 (hr) | Anti-phf-tau antitijela i njihove upotrebe | |
| JP2012516158A5 (https=) | ||
| JP2012501670A5 (https=) | ||
| HRP20171080T1 (hr) | Protutijela s modificiranim affinitetom za fcrn koja potiču uklanjanje antigena | |
| JP2017522043A5 (https=) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| CA2992372A1 (en) | Antibody molecules which bind cd22 | |
| EA201001467A1 (ru) | Моноклональное антитело и способ его использования | |
| JP2018537400A5 (https=) | ||
| JP2015501291A5 (https=) | ||
| JP2012524071A5 (https=) | ||
| EP3169705A2 (en) | Molecules with specificity for cd79 and cd22 | |
| CN103145840A (zh) | Il-12/p40结合蛋白 | |
| KR20170078831A (ko) | Cd3/cd38 t 세포 재표적화 헤테로-이량체성 면역글로불린 및 이들의 제조 방법 |